Corcept Therapeutics
CORT
CORT
317 hedge funds and large institutions have $4.03B invested in Corcept Therapeutics in 2024 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 105 increasing their positions, 105 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 284 → 317 (+33)
0% more repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 105
2.34% less ownership
Funds ownership: 85.74% → 83.4% (-2.3%)
Holders
317
Holding in Top 10
7
Calls
$54.3M
Puts
$33.3M
Top Buyers
| 1 | +$20.9M | |
| 2 | +$16.3M | |
| 3 | +$12.5M | |
| 4 |
MGP
M&G plc
London,
United Kingdom
|
+$11.2M |
| 5 |
SAM
Synergy Asset Management
Vancouver,
Washington
|
+$8.94M |
Top Sellers
| 1 | -$22.6M | |
| 2 | -$22.2M | |
| 3 | -$18.7M | |
| 4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$13.2M |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$12M |